Abstract
Purpose
To evaluate the impact of artificial oocyte activation (AOA) in pregnancy and neonatal outcomes in infertile patients undergoing cryopreserved embryo transfer.
Method
This retrospective study included 5686 patients’ transferred embryos from routine intracytoplasmic sperm injection (ICSI) and 194 patients’ transferred embryos from ICSI combined with AOA (ICSI-AOA) from January 2011 to December 2016. Pregnancy and neonatal outcomes of couples undergoing routine ICSI or ICSI-AOA were analyzed before and after propensity score matching. Artificial oocyte activation was performed with ionomycin.
Results
The pregnancy outcomes showed no significant difference in the rates of biochemical pregnancy, clinical pregnancy, implantation, miscarriage, ectopic pregnancy, multiple pregnancy, and live births between the routine ICSI and ICSI-AOA groups before and after propensity score matching, respectively. The assessment of neonatal outcomes showed no statistically significant differences in the birth defect rate, birth weight, gestational age, preterm birth rate, early-neonatal death rate, and fetal sex ratio between the two groups, and similar results were also observed in the two matched cohorts.
Conclusion
Artificial oocyte activation with ionomycin does not adversely affect pregnancy and neonatal outcomes in patients undergoing frozen–thawed embryo transfer, which is beneficial to clinicians counseling patients on the risks of artificial oocyte activation.
Similar content being viewed by others
References
Kashir J, Heindryckx B, Jones C, de Sutter P, Parrington J, Coward K (2010) Oocyte activation, phospholipase C zeta and human infertility. Hum Reprod Update 16:690–703
Baltaci V, Ayvaz OU, Unsal E, Aktaş Y, Baltaci A, Turhan F et al (2010) The effectiveness of intracytoplasmic sperm injection combined with piezoelectric stimulation in infertile couples with total fertilization failure. Fertil Steril 94:900–904
Kyono K, Takisawa T, Nakajo Y, Doshida M, Toya M (2012) Birth and follow-up of babies born following ICSI with oocyte activation using strontium chloride or calcium ionophore A23187. J Mamm Ova Res 29:35–40
Montag M, Köster M, van der Ven K, Bohlen U, van der Ven H (2012) The benefit of artificial oocyte activation is dependent on the fertilization rate in a previous treatment cycle. Reprod Biomed Online 24:521–526
Yoon HJ, Bae IH, Kim HJ, Jang JM, Hur YS, Kim HK et al (2013) Analysis of clinical outcomes with respect to spermatozoan origin after artificial oocyte activation with a calcium ionophore. J Assist Reprod Genet 30:1569–1575
Ebner T, Montag M, Montag M, Van der Ven K, Van der Ven H et al (2015) Live birth after artificial oocyte activation using a ready-to-use ionophore: a prospective multicentre study. Reprod Biomed Online 30:359–365
Ebner T, Oppelt P, Wöber M, Staples P, Mayer RB, Sonnleitner U et al (2015) Treatment with Ca2+ ionophore improves embryo development and outcome in cases with previous developmental problems: a prospective multicenter study. Hum Reprod 30:97–102
Mansour R, Fahmy I, Tawab NA, Kamal A, El-Demery Y, Aboulghar M et al (2009) Electrical activation of oocytes after intracytoplasmic sperm injection: a controlled randomized study. Fertil Steril 91:133–139
Borges E, de Almeida Ferreira Braga DP, de Sousa Bonetti TC, Iaconelli A, Franco JG (2009) Artificial oocyte activation with calcium ionophore A23187 in intracytoplasmic sperm injection cycles using surgically retrieved spermatozoa. Fertil Steril 92:131–136
Kang HJ, Lee SH, Park YS, Lim CK, Ko DS, Yang KM et al (2015) Artificial oocyte activation in intracytoplasmic sperm injection cycles using testicular sperm in human in vitro fertilization. Clin Exp Reprod Med 42:45–50
Deemeh MR, Tavalaee M, Nasr-Esfahani MH (2015) Health of children born through artificial oocyte activation: a pilot study. Reprod Sci 22:322–328
Borges E, de Almeida Ferreira Braga DP, de Sousa Bonetti TC, Iaconelli A, Franco JG (2009) Artificial oocyte activation using calcium ionophore in ICSI cycles with spermatozoa from different sources. Reprod Biomed Online 18:45–52
Ebner T, Köster M, Shebl O, Moser M, Van der Ven H, Tews G et al (2012) Application of a ready-to-use calcium ionophore increases rates of fertilization and pregnancy in severe male factor infertility. Fertil Steril 98:1432–1437
Du T, Wang Y, Fan Y, Zhang S, Yan Z, Yu W et al (2018) Fertility and neonatal outcomes of embryos achieving blastulation on Day 7: are they of clinical value? Hum Reprod 33:1038–1051
Kuang Y, Hong Q, Chen Q, Lyu Q, Ai A, Fu Y et al (2014) Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen–thawed embryo transfer cycles. Fertil Steril 101:105–111
Chen H, Wang Y, Lyu Q, Ai A, Fu Y, Tian H et al (2015) Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles. Fertil Steril 103:1194–1201
Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology (2011) The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 26:1270–1283
Gardner DK, Schoolcraft WB (1999) In vitro culture of human blastocysts. In: Jansen R, Mortimer D (eds) Toward reproductive certainty: fertility and genetics beyond 1999. Parthenon Publishing, London, pp 378–388
Montjean D, Pauly V, Gervoise-Boyer M, Amar-Hoffet A, Geoffroy-Siraudin C, Boyer P (2019) Is it worth it to cryopreserve embryos with blastulation delay at day 5? Zygote 28:1–6
Nasr-Esfahani MH, Razavi S, Javdan Z, Tavalaee M (2008) Artificial oocyte activation in severe teratozoospermia undergoing intracytoplasmic sperm injection. Fertil Steril 90:2231–2237
Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K et al (2009) International committee for monitoring assisted reproductive technology (ICMART) and the world health organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril 92:1520–1524
Zhu Q, Wang N, Wang B, Wang Y, Kuang Y (2018) The risk of birth defects among children born after vitrified blastocyst transfers and those born after fresh and vitrified cleavage-stage embryo transfers. Arch Gynecol Obstet 298:833–840
Zhu J, Zhu Q, Wang Y, Wang B, Lyu Q, Kuang Y (2019) Comparative study on risk for birth defects among infants after in vitro fertilization and intracytoplasmic sperm injection. Syst Biol Reprod Med 65:54–60
World Health Organization. International statistical classification of diseases and related health problems. Available at: https://apps.who.int/iris/bitstream/10665/61362/1/WHO_MNH_MEP_87.1_REV.2.pdf. Last accessed 17 March 2015
Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S (2011) Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen–thawed embryo transfer in normal responders. Fertil Steril 96:344–348
Cobo A, de los Santos MJ, Castello D, Gamiz P, Campos P, Remohí J (2012) Outcomes of vitrified early cleavage-stage and blastocyst-stage embryos in a cryopreservation program: evaluation of 3150 warming cycles. Fertil Steril 98:1138–1146
Wong KM, van Wely M, Mol F, Repping S, Mastenbroek S (2017) Fresh versus frozen embryo transfers in assisted reproduction. Cochrane Database Syst Rev 28(CD011184):27
Chen ZJ, Shi Y, Sun Y, Zhang B, Liang X, Cao Y et al (2016) Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N Engl J Med 375:523–533
Miller N, Biron-Shental T, Sukenik-Halevy R, Klement AH, Sharony R, Berkovitz A (2016) Oocyte activation by calcium ionophore and congenital birth defects: a retrospective cohort study. Fertil Steril 106:590–596
Wen J, Jiang J, Ding C, Dai J, Liu Y, Xia Y et al (2012) Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis. Fertil Steril 97:1331–1337
Ooki S (2015) Birth defects after assisted reproductive technology according to the method of treatment in Japan: nationwide data between 2004 and 2012. Environ Health Prev Med 20:460–465
Wang N, Lin J, Zhu Q, Fan Y, Wang Y, Fu Y et al (2018) Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: a large retrospective cohort study. Medicine (Baltimore) 97:e11906
Samadirad B, Khamnian Z, Hosseini MB, Dastgiri S (2012) Congenital anomalies and termination of pregnancy in Iran. J Pregnancy 2012:574513
Deng C, Yi L, Mu Y, Zhu J, Qin Y, Fan X, Wang Y, Li Q (2015) Dai L Recent trends in the birth prevalence of down syndrome in China: impact of prenatal diagnosis and subsequent terminations. Prenat Diagn 35(4):311–318
Hollier LM, Leveno KJ, Kelly MA, Mcintire DD, Cunningham FG (2000) Maternal age and malformations in singleton births. Obstet Gynecol 96:701–706
Nasr-Esfahani MH, Deemeh MR, Tavalaee M (2010) Artificial oocyte activation and intracytoplasmic sperm injection. Fertil Steril 94:520–526
Nikiforaki D, Vanden Meerschaut F, de Roo C, Lu Y, Ferrer-Buitrago M, de Sutter P et al (2016) Effect of two assisted oocyte activation protocols used to overcome fertilization failure on the activation potential and calcium releasing pattern. Fertil Steril 105:798–806
Isachenko E, Isachenko V, Todorov P, Ostashko V, Kreienberg R, Kaufmann M et al (2010) Pregnancy after the calcium ionophore correction of pronuclei position in oocytes after intracytoplasmic sperm injection. Fertil Steril 94(2770):e3–5
Whittaker W, Anselmi L, Kristensen SR, Lau YS, Bailey S, Bower P et al (2016) Associations between extending access to primary care and emergency department visits: a difference-in-differences analysis. PLoS Med 13:e1002113
Acknowledgements
The authors thank Meiping Sheng and Suqun Zhang for following up with the patients and auditing the data.
Funding
This work was supported by The National Nature Science Foundation of China (Grant Numbers 81771649 and 81571486).
Author information
Authors and Affiliations
Contributions
ZY and QL were involved in the conception and design, and revision of the article. BL, YZ, and ZY analyzed the data and completed the manuscript writing. SX, YW, RC, YF, QH, ML, and YK completed the collection of clinical data. TD, HL, and MY conducted the statistical analysis.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, B., Zhou, Y., Yan, Z. et al. Pregnancy and neonatal outcomes of artificial oocyte activation in patients undergoing frozen–thawed embryo transfer: a 6-year population-based retrospective study. Arch Gynecol Obstet 300, 1083–1092 (2019). https://doi.org/10.1007/s00404-019-05298-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-019-05298-3